Coronavirus company news summary - UK opens first megalab to boost Covid-19 test and trace capacity - GT Molecular unveils PCR tests for Delta variant and Influenza A and B - Verdict Medical Devices
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Coronavirus company news summary – UK opens first megalab to boost Covid-19 test and trace capacity – GT Molecular unveils PCR tests for Delta variant and Influenza A and B

14 Jul 2021

The UK’s first testing megalab, the Rosalind Franklin Laboratory in Royal Leamington Spa, has opened. The lab will be processing and sequencing thousands of Covid-19 tests every week in an effort to respond to new variants and disease threats in the future. The opening is also expected to create 1,500 skilled jobs for the region. The laboratory is part of the UK’s NHS Test and Trace network, which will be using cutting-edge technology to process more tests and adopt the new genotype assay testing to quickly identify variants and new mutations.

GT Molecular has begun shipping its highly sensitive PCR tests to identify the Covid-19 Delta variant (B.1.617.2), which was first identified in India in December 2020. In addition to SARS-CoV-2 variants, GT molecular tests also detect influenza A and B, helping researchers and policymakers to accurately assess community pathogen levels and make precise data-driven decisions. The company is also offering additional RT-qPCR kits to screen the Gamma, Epsilon, Beta and Alpha variants.

Global WholeHealth Partners (GWHP) has confirmed that its antibody and antigen test kits are able to detect mutated Covid-19 strains.